Close Menu

NEW YORK (GenomeWeb) – Enterome and Nestle Health Science announced today that they have formed a new company to develop microbiome diagnostics for multiple indications including inflammatory bowel disease (IBD) and liver disorders.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.